Ny.TmT Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Ny.TmT General Information

Description

Operator of a therapeutics company intended for curing osteoarthritis and tendinopathy diseases. The company's drug candidate is enteric-coated capsules containing compounds that target a novel OA disease, and TenoGen is a biologic derived from MSCs under a specially-defined physical condition, helping clients in treating and curing musculoskeletal diseases and disorders.

Contact Information

Website
www.nytmt.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 173 Kensington Oval
  • New Rochelle, NY 10805
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 173 Kensington Oval
  • New Rochelle, NY 10805
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ny.TmT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 08-Jul-2021 Completed Generating Revenue
6. Grant 30-Sep-2020 Completed Generating Revenue
5. Grant 01-Jan-2018 Completed Generating Revenue
4. Grant 15-Sep-2017 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Grant 01-Jan-2016 $244K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Ny.TmT’s complete valuation and funding history, request access »

Ny.TmT Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Ny.TmT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026055112-A1 Methods and compositions for arthritis Pending 03-Sep-2024
WO-2025034787-A1 Synthetic 3d scaffold-cultured stem cell-derived exosomes for treating tendon pathologies Inactive 10-Aug-2023
WO-2025034949-A2 Microrna let-7b-5p for treating tendon pathologies Inactive 08-Aug-2023
WO-2025034949-A3 Microrna let-7b-5p for treating tendon pathologies Inactive 08-Aug-2023
US-20230098714-A1 Microrna compositions and methods of use Pending 06-Aug-2021 A61K47/554
To view Ny.TmT’s complete patent history, request access »

Ny.TmT Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Westchester County Biosciences Accelerator Accelerator/Incubator
National Center For Complementary And Integrative Health Government
National Institute on Aging Government
Entrepreneurship Lab Bio & Health Tech NYC Accelerator/Incubator
National Institutes of Health Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Ny.TmT FAQs

  • When was Ny.TmT founded?

    Ny.TmT was founded in 2013.

  • Where is Ny.TmT headquartered?

    Ny.TmT is headquartered in New Rochelle, NY.

  • What industry is Ny.TmT in?

    Ny.TmT’s primary industry is Drug Discovery.

  • Is Ny.TmT a private or public company?

    Ny.TmT is a Private company.

  • What is Ny.TmT’s current revenue?

    The current revenue for Ny.TmT is .

  • Who are Ny.TmT’s investors?

    Westchester County Biosciences Accelerator, National Center For Complementary And Integrative Health, National Institute on Aging, Entrepreneurship Lab Bio & Health Tech NYC, and National Institutes of Health are 5 of 6 investors who have invested in Ny.TmT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process